Almonds for Overweight Active Older Adults
Trial Summary
What is the purpose of this trial?
The overall objective of this proposed randomized, crossover study is to determine the effect of 12 weeks of almond consumption, ingested as a snack twice daily, on energy expenditure, performance and functional related outcomes, in active, overweight, older adults, in comparison to 12 weeks of an isocaloric matched control snack. The central hypothesis of this study is, due to the nutritionally beneficial composition of almonds, that daily consumption of an almond snack for 12 weeks will contribute to improvements in energy expenditure, physical and functional performance, vascular function, inflammation/oxidative stress, sleep quality, mood status, and body composition in active, overweight and obese older adults compared to an isocaloric commercially available snack.
Research Team
Robert Hickner, PhD
Principal Investigator
Florida State University
Eligibility Criteria
This trial is for active, overweight adults aged 50-59 with a BMI of 25.0 to 29.9 kg/m2 who are free from chronic diseases like cancer and cardiovascular conditions. Participants should not be on certain medications, have musculoskeletal issues that limit activity, or be involved in other studies.Inclusion Criteria
Exclusion Criteria
Treatment Details
Interventions
- Almond Consumption (N/A)
- Placebo Consumption (N/A)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Florida State University
Lead Sponsor
Jim Scholefield
Florida State University
Chief Executive Officer since 2023
Bachelor of Science in Management from Florida State University
Dr. Stanley Iyadurai
Florida State University
Chief Medical Officer since 2023
MD and PhD from University of Minnesota
Almond Board of California
Collaborator